Bioengineering

  1. A cell-free nanobody engineering platform rapidly generates SARS-CoV-2 neutralizing nanobodies

    1. Xun Chen
    2. Matteo Gentili
    3. Nir Hacohen
    4. Aviv Regev

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Engineering, production and characterization of Spike and Nucleocapsid structural proteins of SARS–CoV-2 in Nicotiana benthamiana as vaccine candidates against COVID-19

    1. Tarlan Mamedov
    2. Damla Yuksel
    3. Merve Ilgın
    4. İrem Gürbüzaslan
    5. Burcu Gulec
    6. Gulshan Mammadova
    7. Deniz Say
    8. Gulnara Hasanova

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations

    1. Federico Bertoglio
    2. Viola Fühner
    3. Maximilian Ruschig
    4. Philip Alexander Heine
    5. Leila Abassi
    6. Thomas Klünemann
    7. Ulfert Rand
    8. Doris Meier
    9. Nora Langreder
    10. Stephan Steinke
    11. Rico Ballmann
    12. Kai-Thomas Schneider
    13. Kristian Daniel Ralph Roth
    14. Philipp Kuhn
    15. Peggy Riese
    16. Dorina Schäckermann
    17. Janin Korn
    18. Allan Koch
    19. M. Zeeshan Chaudhry
    20. Kathrin Eschke
    21. Yeonsu Kim
    22. Susanne Zock-Emmenthal
    23. Marlies Becker
    24. Margitta Scholz
    25. Gustavo Marçal Schmidt Garcia Moreira
    26. Esther Veronika Wenzel
    27. Giulio Russo
    28. Hendrikus S.P. Garritsen
    29. Sebastian Casu
    30. Andreas Gerstner
    31. Günter Roth
    32. Julia Adler
    33. Jakob Trimpert
    34. Andreas Hermann
    35. Thomas Schirrmann
    36. Stefan Dübel
    37. André Frenzel
    38. Joop Van den Heuvel
    39. Luka Čičin-Šain
    40. Maren Schubert
    41. Michael Hust

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Rapid, high-yield production of full-length SARS-CoV-2 spike ectodomain by transient gene expression in CHO cells

    1. Matthew Stuible
    2. Christian Gervais
    3. Simon Lord-Dufour
    4. Sylvie Perret
    5. Denis L’Abbé
    6. Joseph Schrag
    7. Gilles St-Laurent
    8. Yves Durocher

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2

    1. Jeonghwan Kim
    2. Anindit Mukherjee
    3. Dylan Nelson
    4. Antony Jozic
    5. Gaurav Sahay

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. High affinity modified ACE2 receptors protect from SARS-CoV-2 infection in hamsters

    1. Yusuke Higuchi
    2. Tatsuya Suzuki
    3. Takao Arimori
    4. Nariko Ikemura
    5. Emiko Mihara
    6. Yuhei Kirita
    7. Eriko Ohgitani
    8. Osam Mazda
    9. Daisuke Motooka
    10. Shota Nakamura
    11. Yusuke Sakai
    12. Yumi Itoh
    13. Fuminori Sugihara
    14. Yoshiharu Matsuura
    15. Satoaki Matoba
    16. Toru Okamoto
    17. Junichi Takagi
    18. Atsushi Hoshino

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2

    1. Magnus A.G. Hoffmann
    2. Collin Kieffer
    3. Pamela J. Bjorkman

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. EXPERIMENTAL INVESTIGATION OF PULSE STERILIZATION OF VIRAL INFECTION

    1. Volodymyr Chumakov
    2. Mykhailo Ostryzhnyi
    3. Oksana Kharchenko
    4. Krystina Naumenko
    5. Svitlana Zagorodnya
    6. Vasiliy Muraveinyk
    7. Aleksandr Tarasevich

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. A Neutralizing Antibody-Conjugated Photothermal Nanoparticle Captures and Inactivates SARS-CoV-2

    1. Xiaolei Cai
    2. Aleksander Prominski
    3. Yiliang Lin
    4. Nicholas Ankenbruck
    5. Jillian Rosenberg
    6. Min Chen
    7. Jiuyun Shi
    8. Eugene B. Chang
    9. Pablo Penaloza-MacMaster
    10. Bozhi Tian
    11. Jun Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. CAR Macrophages for SARS-CoV-2 Immunotherapy

    1. Wenyan Fu
    2. Changhai Lei
    3. Zetong Ma
    4. Kewen Qian
    5. Tian Li
    6. Jian Zhao
    7. Shi Hu

    Reviewed by ScreenIT

    4 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 18 of 26 Next